1. Identity of Gli1+ cells in the bone marrow
- Author
-
Julia P. Andreotti, Isabella T. Borges, Gabryella S P Santos, Pedro H.D.M. Prazeres, Daniel A. P. Guerra, Ana E. Paiva, Viviani M. Almeida, Patrick O. Azevedo, Alexander Birbrair, Luiza Lousado, Luanny Souto, Akiva Mintz, and Isadora F. G. Sena
- Subjects
0301 basic medicine ,Cancer Research ,Pathology ,medicine.medical_specialty ,biology ,business.industry ,Cell growth ,Transgene ,Bone marrow failure ,Cell Biology ,Hematology ,medicine.disease ,03 medical and health sciences ,030104 developmental biology ,medicine.anatomical_structure ,In vivo ,GLI1 ,Gene expression ,Genetics ,biology.protein ,Medicine ,Bone marrow ,business ,Myelofibrosis ,Molecular Biology - Abstract
Bone marrow fibrosis is a critical component of primary myelofibrosis in which normal bone marrow tissue and blood-forming cells are gradually replaced with scar tissue. The specific cellular and molecular mechanisms that cause bone marrow fibrosis are not understood. A recent study using state-of-the-art techniques, including in vivo lineage tracing, provides evidence that Gli1+ cells are the cells responsible for fibrotic disease in the bone marrow. Strikingly, genetic depletion of Gli1+ cells rescues bone marrow failure and abolishes myelofibrosis. This work introduces a new central cellular target for bone marrow fibrosis. The knowledge that emerges from this research will be important for the treatment of several malignant and nonmalignant disorders.
- Published
- 2017
- Full Text
- View/download PDF